Bietti
Showing 1 - 25 of 53
Bietti Crystalline Dystrophy Trial in Shanghai (VGR-R01)
Not yet recruiting
- Bietti Crystalline Dystrophy
- VGR-R01
-
Shanghai, Shanghai, ChinaShanghai Vitalgen Biopharma Co.,Ltd.
Jan 20, 2023
Bietti's Crystalline Dystrophy Trial in Beijing (ZVS101e)
Recruiting
- Bietti's Crystalline Dystrophy
-
Beijing, Beijing, ChinaPeking University Third Hospital
Feb 2, 2023
Bietti Crystalline Dystrophy Trial in Beijing (VGR-R01)
Not yet recruiting
- Bietti Crystalline Dystrophy
-
Beijing, Beijing, ChinaWen-Bin Wei
May 26, 2022
Visual Field Change in Glaucoma:Assessment of Different Models
Recruiting
- Glaucoma
-
Milano, Italy
- +1 more
Apr 4, 2023
Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)
Not yet recruiting
- Macular Edema
- +2 more
- subthreshold treatment with micropulsed laser
-
Rome, RM, ItalyIRCSS Fondazione G:B:Bietti
Jul 27, 2023
Cataract, Lens Opacities Trial in Rome (IOL implantation)
Completed
- Cataract
- Lens Opacities
- IOL implantation
-
Rome, Italy
- +1 more
Oct 27, 2022
Primary Open Angle Glaucoma Trial in Roma, Rome (Citicoline, Placebo)
Recruiting
- Primary Open Angle Glaucoma
- Citicoline
- Placebo
-
Roma, Italy
- +1 more
Mar 29, 2022
Inherited Retinal Dystrophies Using Whole Genome Sequencing and
Recruiting
- Inherited Retinal Dystrophy
- +2 more
- whole genome sequencing
-
Rome, ItalyIstituto Superiore di Sanità-Dpt. Oncology and Molecular Medicin
Mar 30, 2023
Macular Degeneration, Senile, Laser Burn of Retina, Macular Degeneration Intermediate Trial in Genova, Milan, Rome (Pascal
Recruiting
- Macular Degeneration, Senile
- +3 more
- Pascal Synthesis 577 sub-threshold laser (Topcon Corporation, Tokyo, Japan)
- Pascal Synthesis 577 sham (Topcon Corporation, Tokyo, Japan)
-
Genova, Italy
- +3 more
Jul 27, 2022
Bietti's Crystalline Dystrophy Trial in Beijing (Gene Replacement Therapy by rAAV2/8-hCYP4V2)
Recruiting
- Bietti's Crystalline Dystrophy
- Gene Replacement Therapy by rAAV2/8-hCYP4V2
-
Beijing, Beijing, ChinaBeijing Tongren Hospital
May 6, 2021
Eyes With Non Proliferative Diabetic Retinopathy in Diabetes
Recruiting
- NPDR - Non Proliferative Diabetic Retinopathy
- +2 more
- Biomarkers
-
Dijon, France
- +4 more
Jul 18, 2022
Glaucoma, Open-Angle, Ocular Hypertension Trial in Milano, Pavia, Roma (tafluprost/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
-
Milano, Italy
- +2 more
Mar 18, 2022
Development of Novel Clinical Endpoints in Intermediate AMD
Active, not recruiting
- Age Related Macular Degeneration (AMD)
- No intervention
-
Copenhagen, Denmark
- +19 more
May 23, 2022
Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-149 dose level 1, THR-149 dose level 2, THR-149
Recruiting
- Diabetes Mellitus
- +2 more
- THR-149 dose level 1
- +6 more
-
Beverly Hills, California
- +60 more
Aug 9, 2022
Neurodegenerative Diseases Trial in Roma (Citicoline)
Completed
- Neurodegenerative Diseases
-
Roma, ItalyFondazione G.B. Bietti- IRCCS
Jun 27, 2019
Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)
Recruiting
- Diabetic Retinopathy
- Runcaciguat (BAY1101042)
- Placebo
-
Redlands, California
- +85 more
Jan 30, 2023
Macular Holes Trial in Campobasso (Cover Group, Fill Group)
Unknown status
- Macular Holes
- Cover Group
- Fill Group
-
Campobasso, ItalyUniversity of Molise
Oct 19, 2019
Elderly Subjects (PROMISING)
Recruiting
- Ageing
- Frailty
- comprehensive geriatric asssessment
-
Cosenza, ItalyIRCCS INRCA Hospital
Apr 7, 2023
Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Netarsudil/Latanoprost 0.02%/0.005%, GANFORT®)
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Netarsudil/Latanoprost 0.02%/0.005%
- GANFORT®
-
Graz, Austria
- +67 more
Jan 24, 2022
Cataract Trial in Italy, Slovakia, Spain (Chloroprocaine 3%, Tetracaine 0.5%)
Completed
- Cataract
- Chloroprocaine 3%
- Tetracaine 0.5%
-
Bologna, Italy
- +26 more
Apr 19, 2021
Progressive Keratoconus Trial in Rome (Cross-linking with iontophoresis, Standard corneal cross-linking)
Completed
- Progressive Keratoconus
- Cross-linking with iontophoresis
- Standard corneal cross-linking
-
Rome, ItalyFondazione G.B. Bietti, IRCCS
Aug 2, 2019
Diabetic Macular Edema Trial in Bergamo, Catanzaro, Rome (DIABEC plus intravitreal dexamethazone)
Completed
- Diabetic Macular Edema
- DIABEC plus intravitreal dexamethazone
-
Bergamo, Italy
- +2 more
Jul 30, 2019